BMJ  2006;332:803-804 (8 April), doi:10.1136/bmj.332.7545.803

Editorial

Ecstasy and the antecedents of illicit drug use

Anxiety and depression may be risk factors for using ecstasy

The first 150 words of the full text of this article appear below.

Ecstasy (3-4 methylenedioxymethamphetamine, MDMA) is a synthetic, psychoactive drug chemically similar to the stimulant methamphetamine and the hallucinogen mescaline. It is neurotoxic for animals and a health risk for humans.1 Most users are young, and use has increased in most European countries where annual survey data are available, now exceeding amphetamine use in some. In Europe recent lifetime experience rates range from 0.4% to 13% among 15-24-year olds; in the United States the rate is 14.8% among 18-25 year olds.2 However, surveys probably underestimate the number of users.3 Ecstasy users often use other illicit drugs,4 raising the question why young people take addictive drugs.

To become addicted to something, you must first be able to obtain it; then you have to try it, you must instantly like it or learn to like it, you must start to think that you need it, and you must like the rewards more . . . [Full text of this article]

Kari Poikolainen, research director

Finnish Foundation for Alcohol Studies, PO Box 220, FIN-00531, Helsinki, Finland
(kari.poikolainen@stakes.fi)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Anxiety and depression in childhood may raise risk of ecstasy use
BMJ 2006 332: 0. [Full Text]

Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study
Anja C Huizink, Robert F Ferdinand, Jan van der Ende, and Frank C Verhulst
BMJ 2006 332: 825-828. [Abstract] [Full Text] [PDF]

Multicentre controlled trial of parenting groups for childhood antisocial behaviour in clinical practice Commentary: nipping conduct problems in the bud
Stephen Scott, Quentin Spender, Moira Doolan, Brian Jacobs, Helen Aspland, and Carolyn Webster-Stratton
BMJ 2001 323: 194. [Abstract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ